>
>
Pharmaceuticals Machinery Market Size - By Machine Type, By Mode of Operation, By Application, By Distribution Channel Analysis, Share, Growth Forecast, 2025 - 2034
Report ID: GMI13026
|
Published Date: January 2025
|
Report Format: PDF
Download free sample
Get a free sample of Pharmaceuticals Machinery Market
Get a free sample of Pharmaceuticals Machinery Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 15
Tables & Figures: 180
Countries covered: 18
Pages: 220
Download Free Sample
Pharmaceuticals Machinery Market Size
The global pharmaceuticals machinery market was valued at USD 25.2 billion in 2024 and is estimated to grow at a CAGR of over 6.4% from 2025 to 2034, driven by rising pharmaceutical demand, technological advancements, a growing biopharmaceutical sector, strict regulatory standards, increased generic drug production, and expanding vaccine and injectable drug manufacturing. The growth of pharmaceutical contract manufacturing also contributes significantly to the market growth.
Population growth, especially in developing countries, is boosting the demand for pharmaceuticals, requiring efficient machinery to produce medications at scale. Additionally, the aging global population is driving demand for treatments for chronic diseases like diabetes, cardiovascular conditions, and neurological disorders, further increasing the need for advanced manufacturing systems.
Technologies like automation, artificial intelligence (AI), and robotics are transforming pharmaceutical manufacturing by improving efficiency, accuracy, and scalability. These innovations reduce human errors, enhance productivity, and ensure regulatory compliance, fueling demand for advanced machinery. The production of biologics, vaccines, and biosimilars also requires specialized equipment, such as high-precision fill-finish systems and sterile processing systems, making this a key growth area. Moreover, contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) are investing in advanced machinery to support large-scale production for multiple pharmaceutical companies, further driving market growth.
Pharmaceuticals Machinery Market Trends
Pharmaceutical manufacturers are adopting automation to boost efficiency, reduce errors, and increase production capacity. Automated systems ensure greater precision, improving productivity and consistency. The growing production of biologics and biosimilars is driving demand for specialized equipment like fill-finish systems, fermentation units, and lyophilizes. Additionally, personalized medicine is increasing the need for flexible machinery capable of handling small-batch production, diverse formulations, and varying dosages.
Pharmaceuticals Machinery Market Analysis
The pharmaceuticals machinery industry faces several growth challenges, including high initial costs, operational complexities, regulatory hurdles, supply chain disruptions, and environmental concerns. Advanced pharmaceuticals machinery is expensive, making it difficult for small and medium-sized pharmaceutical companies to scale up production. These machines require skilled operators, which is a challenge in regions with a shortage of trained personnel. Pharmaceutical machinery, particularly large-scale systems, consumes significant energy. Rising environmental concerns and stricter regulations, especially in developed economies, are pushing manufacturers to adopt energy-efficient, eco-friendly machines. However, these investments are costly and may impact product competitiveness.
Based on machine type, the solid dosage machine segment accounted for revenue of around USD 9.6 billion in 2024 and is estimated to grow at a CAGR of 6.8% from 2025 to 2034. Solid dosage forms, such as tablets, capsules, and powders, dominate pharmaceutical manufacturing. Trends focus on efficiency, customization, and compliance, driven by demand for automated, high-speed production.
Furthermore, processing machines are key to converting active pharmaceutical ingredients (APIs) into final products. The rise of biologics and biosimilars boosts demand for specialized equipment like fermentation tanks, mixers, and dryers. Automation streamlines processes, enabling continuous systems that improve efficiency and reduce errors.
Based on the mode of operation, the fully automatic segment held around 61% share of the pharmaceuticals machinery market in 2024 and is anticipated to grow at a CAGR of 6.6% from 2025 to 2034. Fully automatic machinery is crucial for high-speed, large-scale production of pharmaceutical products like tablets, capsules, and injectables. These machines manage filling, capping, labeling, and packaging, enabling manufacturers to meet rising demand efficiently.
Furthermore, semi-automatic machinery combines manual intervention with automation in key areas to improve efficiency, reduce errors, and ensure consistent quality. Commonly used for medium-scale production, these machines are popular among small and medium-sized manufacturers, offering a cost-effective way to scale production without the expense of fully automatic systems.
U.S. pharmaceuticals machinery market size exceeded USD 5.7 billion in 2024 and is estimated to grow at a CAGR of 6.5% from 2025 to 2034, due to rising demand for pharmaceutical products, advancements in technology, personalized and small-batch production, biopharmaceutical focus, and vaccine manufacturing innovations.
Chronic diseases, an aging population, and increased healthcare needs are driving demand for medications, including those for chronic conditions, cancer, and infectious diseases. This has led pharmaceutical companies to invest in scalable, efficient manufacturing equipment. The shift toward biopharmaceuticals, such as biologics and biosimilars, requires specialized machinery for complex processes like fermentation, sterile filling, and lyophilization, boosting market growth. Furthermore, automation, IoT, and Industry 4.0 technologies are key growth drivers. These innovations enhance production efficiency, precision, and quality control while reducing downtime and improving flexibility through predictive maintenance and real-time monitoring.
Country-level Analysis
North America: In terms of the country, the US dominates with an overall market share of around 79% in North America, due to rising demand for pharmaceutical products, advancements in technology, personalized and small-batch production, biopharmaceutical focus, and vaccine manufacturing innovations.
On the other hand, Canada pharmaceuticals machinery market expressing notable growth rate of 5.1% from 2025 to 2034. Canada's pharmaceutical sector is growing rapidly in biologics and biosimilars, requiring advanced technologies like bioreactors, fermentation systems, sterile fill-finish lines, and cleanroom environments.
Europe: The Europe pharmaceuticals machinery market accounted for around 23% revenue share in 2024 and anticipated to grow with a CAGR of 5.8% from 2025 to 2034. Europe's aging population is driving demand for pharmaceuticals, particularly for chronic diseases, oncology, and age-related conditions like Alzheimer's and cardiovascular diseases. This demand is pushing manufacturers to invest in scalable and efficient pharmaceutical machinery.
In terms of country, Germany pharmaceuticals machinery market expressing notable growth rate of 6.7% from 2025 to 2034. Germany, Europe's largest pharmaceutical market and the fourth largest globally, relies on a strong domestic industry and export demand. Leading pharmaceutical companies in Germany are investing in advanced machinery to meet rising drug needs.
Asia Pacific: The Asia Pacific pharmaceuticals machinery marked with a market share of 39% in 2024 and anticipated to grow with a CAGR of around 7.1% from 2025 to 2034. Asia Pacific has become a global hub for generic drug manufacturing due to cost advantages, large production capacities, and a skilled workforce. Increased production in India and China is boosting demand for cost-effective pharmaceutical machinery.
In terms of country, India is emerging as a fastest growing country for the pharmaceutical’s machinery market in terms of CAGR of 7.7% between 2025 to 2034. India's expanding biopharmaceutical production, including vaccines and biosimilars, is driving demand for specialized equipment like bioreactors, sterile fill-finish lines, and cleanroom systems.
Pharmaceuticals Machinery Market Share
In 2024, key companies like Bausch+Strobel, Fette Compacting, GEA, IMA and Syntegon Technology held a combined market share of 20%-25%. These companies are actively engaging in mergers, acquisitions, facility expansions, and collaborations to enhance their product portfolios, reach more customers, and strengthen their market positions.
Companies are introducing advanced machinery with automation, precision, and Industry 4.0 integration. Manufacturers incorporating AI for predictive maintenance and robotics to boost production efficiency. Demand is rising for flexible machinery suited for small batch production and personalized medicine. Companies offering adaptable, customized solutions are gaining a competitive edge in niche markets.
Pharmaceuticals Machinery Market Companies
Major players operating in the pharmaceuticals machinery industry are:
Pharmaceuticals Machinery Industry News
This pharmaceuticals machinery market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Billion) & volume (Thousand Units) from 2021 to 2034, for the following segments:
Click here to Buy Section of this Report
Market, By Machine Type
Market, By Mode of Operation
Market, By Application
Market, By Distribution Channel
The above information is provided for the following regions and countries: